The department has identified specific demographics for the initial phase of the rollout to ensure the most vulnerable ...

Add Yahoo as a preferred source to see more of our stories on Google. Lenacapavir is now approved to prevent HIV infection as well as to treat certain infections. - Gilead Sciences Inc. A drug ...

The New York Times is reporting that a single infusion could suppress HIV for years. This gene therapy uses the same ...

Human immunodeficiency virus (HIV) affects a person’s immune system. People with HIV can take medication to prevent it from progressing to acquired immunodeficiency syndrome (AIDS). However, HIV ...

Add Yahoo as a preferred source to see more of our stories on Google. The U.S. Food and Drug Administration has approved the drug lenacapavir as a twice-yearly injection to prevent HIV. The drug, ...

While delivering the Department of Health's budget vote, the Minister of Health, Dr Aaron Motsoaledi, announced that South ...

The Ebonyi State government has officially launched the Long-Lasting Injectable Pre–Exposure Prophylaxis, Lenacapavir (LEN ...

On June 5, South Africa will unveil lenacapavir, a revolutionary long-acting HIV prevention injection, poised to transform ...

The Food and Drug Administration approved Gilead's twice-yearly antiviral drug for preventing HIV. The company and some experts say it is a milestone that could help bring the world closer to ending ...

In the long battle to create an effective HIV vaccine, scientists have made a major leap forward. A new study shows that a series of vaccines can coax the immune system to produce powerful antibodies ...

A designed chimeric virus induced broadly neutralizing antibodies (bNAbs) against the macaque equivalent of HIV. The strategy ...

The U.S. Food and Drug Administration has approved the drug lenacapavir as a twice-yearly injection to prevent HIV. The drug, called Yeztugo from company Gilead Sciences, was approved Wednesday based ...